Aviceda Therapeutics

Cambridge, MA

Aviceda Therapeutics is a late-stage, pre-clinical stage biotech company focused on the next generation of immuno-modulators by harnessing the power of glycobiology to address the innate immune system and chronic non-resolving inflammation specifically and profoundly.

Company Details

Founded: 2018
Employees: Between 20 - 50 employees
Raised: $276,810,976
Headquarters Location: Cambridge, MA
Public: No
Acquired: No
CEO: Mohamed Genead
Founders: Mohamed Genead
Michael Tolentino
Derek Kunimoto
Christopher Scott

Company Collections

These are collections Aviceda Therapeutics is a part of. Click on the collection name to view similar companies.

Aviceda Therapeutics' Industries

Medical Organizations

Biotechnology Companies